Mubadala Bio and Eli Lilly Announce Pharmaceutical Packaging and Logistics Collaboration

On 20 October 2026, Mubadala Bio and Eli Lilly announced a strategic collaboration to advance the local packaging and logistics of Lilly’s GLP-1 medicines in Abu Dhabi. The commercial value was not disclosed, but the agreement highlights potential demand for pharmaceutical manufacturing support, supply-chain systems and temperature-sensitive logistics analytics; contact HPC for a quotation on operational data processing and computing infrastructure.